Ryanodine receptor antibodies in myasthenia gravis: Epitope mapping and effect on calcium release in vitro

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Muscle and Nerve

• Publication date

  2003-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/mus.10294PMID 12508299
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lounging in a lysosome: the intracellular lifestyle of Coxiella burnetii

  2007cited by this paper
• Molecular Cloning: A Laboratory Manual

  2001cited by this paper
• Striational autoantibodies in myasthenia gravis patients recognize I-band titin epitopes.

  1998cited by this paper
• The Cytoplasmic Loops between Domains II and III and Domains III and IV in the Skeletal Muscle Dihydropyridine Receptor Bind to a Contiguous Site in the Skeletal Muscle Ryanodine Receptor*

  1998cited by this paper
• Spontaneous thymoma rat as a model for myasthenic weakness caused by anti‐ryanodine receptor antibodies

  1998cited by this paper
• Motor Dysfunction and Autoantibodies in Spontaneous Thymoma Buffalo/Mna Rats

  1998cited by this paper
• Myasthenia gravis sera containing antiryanodine receptor antibodies inhibit binding of [3H]‐ryanodine to sacroplasmic reticulum

  1998cited by this paper
• A 37-Amino Acid Sequence in the Skeletal Muscle Ryanodine Receptor Interacts with the Cytoplasmic Loop between Domains II and III in the Skeletal Muscle Dihydropyridine Receptor*

  1998cited by this paper
• Functional Interactions between Cytoplasmic Domains of the Skeletal Muscle Ca2+ Release Channel*

  1997cited by this paper
• Striational autoantibodies in myasthenia gravis mainly react with ryanodine receptor

  1997cited by this paper
• Role of Malignant Hyperthermia Domain in the Regulation of Ca2+ Release Channel (Ryanodine Receptor) of Skeletal Muscle Sarcoplasmic Reticulum*

  1996cited by this paper
• Epitope spreading

  1996cited by this paper
• Broken dogma: penetration of autoantibodies into living cells.

  1996cited by this paper
• Ryanodine receptor antibodies are associated with severe myasthenia gravis

  1996cited by this paper
• Box 1. Autoantibodies that penetrate cells

  1996cited by this paper
• Titin antibodies in patients with late onset myasthenia gravis: clinical correlations.

  1995cited by this paper
• Structure and function of ryanodine receptors.

  1994cited by this paper
• Response to human acetylcholine receptor alpha 138-199: determinant spreading initiates autoimmunity to self-antigen in rabbits.

  1994cited by this paper
• Ryanodine receptor antibodies related to severity of thymoma associated myasthenia gravis.

  1994cited by this paper
• Anti-cardiac ryanodine receptor antibodies in thymoma-associated myasthenia gravis.

  1994cited by this paper
• Mechanisms of fatigue in normal intercostal muscle and muscle from patients with myasthenia gravis

  1993cited by this paper
• Titin antibodies in myasthenia gravis

  1993cited by this paper
• IgG subclass distribution of ryanodine receptor autoantibodies in patients with myasthenia gravis and thymoma.

  1993cited by this paper
• Identification of the domain recognized by anti-(ryanodine receptor) antibodies which affect Ca(2+)-induced Ca2+ release.

  1993cited by this paper
• Myasthenia gravis patients with a thymoma have antibodies against a high molecular weight protein in sarcoplasmic reticulum.

  1992cited by this paper
• Ryanodine receptor autoantibodies in myasthenia gravis patients with a thymoma

  1992cited by this paper
• Responses of intercostal muscle biopsies from normal subjects and patients with myasthenia gravis

  1990cited by this paper
• A novel hydrogel matrix on gold surfaces in surface plasmon resonance sensors for fast and efficient covalent immobilization of ligands

  1990cited by this paper
• Detection of antigen—antibody interactions by surface plasmon resonance. Application to Epitope Mapping

  1990cited by this paper
• Regions of the skeletal muscle dihydropyridine receptor critical for excitation–contraction coupling

  1990cited by this paper
• Myasthenia gravis.

  1988cited by this paper
• Drug-induced Ca2+ release from isolated sarcoplasmic reticulum. II. Releases involving a Ca2+-induced Ca2+ release channel.

  1987cited by this paper
• The Ultrastructural Localization of Antigens for Skeletal Muscle Antibodies in Myasthenia Gravis

  1987cited by this paper
• Dissection of Mycobacterium tuberculosis antigens using recombinant DNA.

  1985cited by this paper
• Protein blotting in uniform or gradient electric fields.

  1985cited by this paper
• Preparation and morphology of sarcoplasmic reticulum terminal cisternae from rabbit skeletal muscle

  1984cited by this paper
• Rapid improvement of myasthenia gravis after plasma exchange?

  1983cited by this paper
• Rapid improvement of myasthenia gravis after plasma exchange

  1982cited by this paper
• Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

  1979cited by this paper
• Determination of acetylcholine receptor antibody in myasthenia gravis: clinical usefulness and pathogenetic implications.

  1978cited by this paper
• Myasthenia Gravis

  1975cited by this paper
• The skeletal muscle binding site of antistriated muscle antibody in myasthenia gravis: an electron microscopic immunohistochemical study using peroxidase conjugated antibody fragments.

  1973cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper

• Atypical Seropositive Striated Muscle Antibody Myasthenia Gravis Presentation With Metastatic B1 Thymoma: A Rare Case

  2023cites this paper
• Overview of biomarkers in myasthenia gravis

  2022cites this paper
• Analysis of nAChR Autoantibodies Against Extracellular Epitopes in MG Patients

  2022cites this paper
• Myasthenia Gravis: From the Viewpoint of Pathogenicity Focusing on Acetylcholine Receptor Clustering, Trans-Synaptic Homeostasis and Synaptic Stability

  2020cites this paper
• Immunopathology of Autoimmune Myasthenia Gravis: Implications for Improved Testing Algorithms and Treatment Strategies

  2020cites this paper
• Autoantibody Specificities in Myasthenia Gravis; Implications for Improved Diagnostics and Therapeutics

  2020influential citation
• Myasthenia Gravis: Autoantibody Specificities and Their Role in MG Management

  2020cites this paper
• Cytometric cell-based assays for anti-striational antibodies in myasthenia gravis with myositis and/or myocarditis

  2019cites this paper
• Myasthenia gravis: State of the art and new therapeutic strategies

  2019cites this paper
• Serological diagnosis of myasthenia gravis and its clinical significance

  2019cites this paper
• Myasthenia Gravis and Other Immune-Mediated Disorders of the Neuromuscular Junction

  2019cites this paper
• Synaptic Compensatory Mechanism and its Impairment in Autoimmune Myasthenic Diseases

  2019cites this paper
• Generalized Myasthenia Gravis: Classification, Clinical Presentation, Natural History, and Epidemiology.

  2018cites this paper
• Paraneoplastic Syndromes and Thymic Malignancies: An Examination of the International Thymic Malignancy Interest Group Retrospective Database

  2017cites this paper
• Myasthenia Gravis.

  2016cites this paper
• Myasthenia gravis — autoantibody characteristics and their implications for therapy

  2016cites this paper
• Myasthenia gravis: subgroup classification and therapeutic strategies

  2015cites this paper
• Cardiac Dysfunction in Myasthenic Crisis

  2014cites this paper
• Can a rare form of myasthenia gravis shed additional light on disease mechanisms?

  2013cites this paper
• Early effect of tacrolimus in improving excitation-contraction coupling in myasthenia gravis.

  2012cites this paper
• Muscle autoantibodies in myasthenia gravis: beyond diagnosis?

  2012cites this paper
• Structure of the neuromuscular junction: function and cooperative mechanisms in the synapse

  2012cites this paper
• Autoanticorps antirécepteurs cholinergiques

  2012cites this paper
• Contribution of anti-ryanodine receptor antibody to impairment of excitation-contraction coupling in myasthenia gravis.

  2012cites this paper
• Three Types of Striational Antibodies in Myasthenia Gravis

  2011cites this paper
• In response to “current approach to seronegative myasthenia” by Z. Argov

  2010cites this paper
• Genetic associations in myasthenia gravis. Implications for pathogenesis

  2010cites this paper
• The auto-antigen repertoire in myasthenia gravis

  2010cites this paper
• Myasthenia gravis in the elderly

  2009cites this paper
• Autoantibodies against TRPC3 and ryanodine receptor in myasthenia gravis.

  2008cites this paper
• Myasthenia Gravis in the Elderly

  2008cites this paper
• [Myasthenic myopathy].

  2007cites this paper
• Myasthenia gravis patients with ryanodine receptor antibodies have distinctive clinical features

  2007cites this paper
• Autoantibodies in neuromuscular autoimmune disorders

  2006cites this paper
• Autoanticorps dans la myasthénie

  2006cites this paper
• Autoanticorps antirécepteurs et autoanticorps anticanaux transmembranaires. Partie 3

  2006cites this paper
• Titin and ryanodine receptor antibodies in myasthenia gravis

  2006cites this paper
• [Antireceptor and antichannel autoantibodies].

  2006cites this paper
• Myasthenia gravis: clinical, immunological, and therapeutic advances

  2005cites this paper
• Seronegative myasthenia gravis: disease severity and prognosis

  2005cites this paper
• Striational antibodies in myasthenia gravis: reactivity and possible clinical significance.

  2005cites this paper
• Proliferating brain cells are a target of neurotoxic CSF in systemic autoimmune disease.

  2005cites this paper
• The role of complement in myasthenia gravis: serological evidence of complement consumption in vivo.

  2005cites this paper
• Survey of the year 2003 commercial optical biosensor literature

  2005cites this paper
• Anti-ryanodine receptor antibodies and FK506 in myasthenia gravis

  2004cites this paper
• Thymectomy in Nonthymoma Early-Onset Myasthenia gravis in Correlation with Disease Severity and Muscle Autoantibodies

  2003cites this paper
• Pathogenesis of Myositis and Myasthenia Associated with Titin and Ryanodine Receptor Antibodies

  2003cites this paper
• Thymectomy and Antimuscle Antibodies in Nonthymomatous Myasthenia Gravis

  2003cites this paper
• Intracellular calcium channels and their modulators

  2003cites this paper
• Disease severity and outcome in thymoma myasthenia gravis: a long‐term observation study

  2003cites this paper
• Treatment ofmuscular dystrophies : present and future

  2003cites this paper
• Muscle Autoantibodies in Myasthenia Gravis: beyond Diagnosis? Nih Public Access Author Manuscript

  year unknowncites this paper